In addition, ProQR Therapeutics (PRQR) sold 3.52M shares of common stock to existing shareholder Eli Lilly (LLY). Evercore ISI, Cantor Fitzgerald, Raymond James and Oppenheimer acted as joint book running managers for the offering.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRQR: